
Felipe Couñago/X
Aug 4, 2025, 19:06
Felipe Couñago: Review on GnRH Antagonists in Prostate Cancer in Arch Esp Urol
Felipe Couñago, National Clinical Director of GenesisCare Spain, shared a post on X:
“Just out!
Review on GnRH antagonists in prostate cancer in Arch Esp Urol.
- No flare
- Fast T suppression
- Possible CV benefit
But evidence still evolving.
Thanks to all co-authors!”
Title: GnRH Antagonists: Current Evidence and Role in Prostate Cancer
Authors: Antonio Lazo, Manuel Blanco, Abrahams Ocanto, Victor Duque-Santana, Rocio Del Castillo, Marta Barrado, Juan Zafra, Fernando López-Campos, Felipe Couñago
Read the Full Article.
More posts featuring Felipe Couñago.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 5, 2025, 06:08
Aug 5, 2025, 05:56
Aug 5, 2025, 05:42
Aug 5, 2025, 05:24
Aug 5, 2025, 04:56
Aug 5, 2025, 04:32